The participation of IGC Pharma's CEO and CCO in a fireside chat to discuss significant advancements in their product pipeline and strategic initiatives is likely to generate positive investor sentiment. The focus on Alzheimer's, metabolic disorders, and AI integration highlights growth potential and innovation, which could positively impact the stock price.